Circulating tumor cells in gastrointestinal cancer

Hiroya Takeuchi, Yuukou Kitagawa

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Since the first report in the nineteenth century, there have been numerous reports on the isolation and characterization of circulating tumor cells (CTCs) in peripheral blood in patients with various carcinomas. In general, CTCs have been observed in the peripheral blood of cancer patients at very low concentrations of 10-7-10-8 of normal peripheral blood cells. The characterization is of considerable biomedical interest in order to understand how these cells can travel via the blood stream to anatomically distant sites and form metastatic disease. Recent progress in molecular oncology enables us to detect the CTCs in blood with highly sensitivity and specificity, and several studies have indicated the prognostic value of CTC detection in patients with gastrointestinal cancers. Detection and measurement of CTCs in patients with gastrointestinal cancers such as colorectal, gastric, and pancreatic cancers can be useful as a promising tool for judging tumor stage, predicting the distant metastasis and patient survival, and monitoring the response to cancer therapy. Standard procedures for CTC detection have to be established, and the clinical relevance should be verified in large-scale clinical trials. However, CTC detection is suggested to provide useful information for the tumor staging and anticancer treatments in clinical practices in the near future.

Original languageEnglish
Pages (from-to)577-582
Number of pages6
JournalJournal of Hepato-Biliary-Pancreatic Sciences
Volume17
Issue number5
DOIs
Publication statusPublished - 2010 Sep

Fingerprint

Circulating Neoplastic Cells
Gastrointestinal Neoplasms
Neoplasms
Neoplasm Staging
Physiologic Monitoring
Pancreatic Neoplasms
Stomach Neoplasms
Colorectal Neoplasms
Blood Cells
Clinical Trials
Neoplasm Metastasis
Carcinoma
Sensitivity and Specificity
Survival
Therapeutics

Keywords

  • Circulating tumor cells
  • Gastrointestinal cancer

ASJC Scopus subject areas

  • Hepatology
  • Surgery
  • Medicine(all)

Cite this

Circulating tumor cells in gastrointestinal cancer. / Takeuchi, Hiroya; Kitagawa, Yuukou.

In: Journal of Hepato-Biliary-Pancreatic Sciences, Vol. 17, No. 5, 09.2010, p. 577-582.

Research output: Contribution to journalArticle

@article{30334fd97f3d4f3c8a914d7a8fe82655,
title = "Circulating tumor cells in gastrointestinal cancer",
abstract = "Since the first report in the nineteenth century, there have been numerous reports on the isolation and characterization of circulating tumor cells (CTCs) in peripheral blood in patients with various carcinomas. In general, CTCs have been observed in the peripheral blood of cancer patients at very low concentrations of 10-7-10-8 of normal peripheral blood cells. The characterization is of considerable biomedical interest in order to understand how these cells can travel via the blood stream to anatomically distant sites and form metastatic disease. Recent progress in molecular oncology enables us to detect the CTCs in blood with highly sensitivity and specificity, and several studies have indicated the prognostic value of CTC detection in patients with gastrointestinal cancers. Detection and measurement of CTCs in patients with gastrointestinal cancers such as colorectal, gastric, and pancreatic cancers can be useful as a promising tool for judging tumor stage, predicting the distant metastasis and patient survival, and monitoring the response to cancer therapy. Standard procedures for CTC detection have to be established, and the clinical relevance should be verified in large-scale clinical trials. However, CTC detection is suggested to provide useful information for the tumor staging and anticancer treatments in clinical practices in the near future.",
keywords = "Circulating tumor cells, Gastrointestinal cancer",
author = "Hiroya Takeuchi and Yuukou Kitagawa",
year = "2010",
month = "9",
doi = "10.1007/s00534-009-0193-4",
language = "English",
volume = "17",
pages = "577--582",
journal = "Journal of Hepato-Biliary-Pancreatic Sciences",
issn = "1868-6974",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Circulating tumor cells in gastrointestinal cancer

AU - Takeuchi, Hiroya

AU - Kitagawa, Yuukou

PY - 2010/9

Y1 - 2010/9

N2 - Since the first report in the nineteenth century, there have been numerous reports on the isolation and characterization of circulating tumor cells (CTCs) in peripheral blood in patients with various carcinomas. In general, CTCs have been observed in the peripheral blood of cancer patients at very low concentrations of 10-7-10-8 of normal peripheral blood cells. The characterization is of considerable biomedical interest in order to understand how these cells can travel via the blood stream to anatomically distant sites and form metastatic disease. Recent progress in molecular oncology enables us to detect the CTCs in blood with highly sensitivity and specificity, and several studies have indicated the prognostic value of CTC detection in patients with gastrointestinal cancers. Detection and measurement of CTCs in patients with gastrointestinal cancers such as colorectal, gastric, and pancreatic cancers can be useful as a promising tool for judging tumor stage, predicting the distant metastasis and patient survival, and monitoring the response to cancer therapy. Standard procedures for CTC detection have to be established, and the clinical relevance should be verified in large-scale clinical trials. However, CTC detection is suggested to provide useful information for the tumor staging and anticancer treatments in clinical practices in the near future.

AB - Since the first report in the nineteenth century, there have been numerous reports on the isolation and characterization of circulating tumor cells (CTCs) in peripheral blood in patients with various carcinomas. In general, CTCs have been observed in the peripheral blood of cancer patients at very low concentrations of 10-7-10-8 of normal peripheral blood cells. The characterization is of considerable biomedical interest in order to understand how these cells can travel via the blood stream to anatomically distant sites and form metastatic disease. Recent progress in molecular oncology enables us to detect the CTCs in blood with highly sensitivity and specificity, and several studies have indicated the prognostic value of CTC detection in patients with gastrointestinal cancers. Detection and measurement of CTCs in patients with gastrointestinal cancers such as colorectal, gastric, and pancreatic cancers can be useful as a promising tool for judging tumor stage, predicting the distant metastasis and patient survival, and monitoring the response to cancer therapy. Standard procedures for CTC detection have to be established, and the clinical relevance should be verified in large-scale clinical trials. However, CTC detection is suggested to provide useful information for the tumor staging and anticancer treatments in clinical practices in the near future.

KW - Circulating tumor cells

KW - Gastrointestinal cancer

UR - http://www.scopus.com/inward/record.url?scp=79651475290&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79651475290&partnerID=8YFLogxK

U2 - 10.1007/s00534-009-0193-4

DO - 10.1007/s00534-009-0193-4

M3 - Article

C2 - 19812887

AN - SCOPUS:79651475290

VL - 17

SP - 577

EP - 582

JO - Journal of Hepato-Biliary-Pancreatic Sciences

JF - Journal of Hepato-Biliary-Pancreatic Sciences

SN - 1868-6974

IS - 5

ER -